United Therapeutics Statistics
Total Valuation
UTHR has a market cap or net worth of $17.05 billion. The enterprise value is $12.62 billion.
| Market Cap | 17.05B |
| Enterprise Value | 12.62B |
Important Dates
The last earnings date was Wednesday, October 30, 2024, before market open.
| Earnings Date | Oct 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
UTHR has 44.64 million shares outstanding. The number of shares has decreased by -1.36% in one year.
| Current Share Class | 44.64M |
| Shares Outstanding | 44.64M |
| Shares Change (YoY) | -1.36% |
| Shares Change (QoQ) | +1.89% |
| Owned by Insiders (%) | 1.75% |
| Owned by Institutions (%) | 98.64% |
| Float | 40.95M |
Valuation Ratios
The trailing PE ratio is 16.58 and the forward PE ratio is 13.00. UTHR's PEG ratio is 0.91.
| PE Ratio | 16.58 |
| Forward PE | 13.00 |
| PS Ratio | 6.25 |
| Forward PS | 5.14 |
| PB Ratio | 2.76 |
| P/FCF Ratio | 18.73 |
| PEG Ratio | 0.91 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.93, with an EV/FCF ratio of 14.05.
| EV / Earnings | 11.36 |
| EV / Sales | 4.58 |
| EV / EBITDA | 8.93 |
| EV / EBIT | 9.38 |
| EV / FCF | 14.05 |
Financial Position
The company has a current ratio of 4.58, with a Debt / Equity ratio of 0.07.
| Current Ratio | 4.58 |
| Quick Ratio | 4.20 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.28 |
| Debt / FCF | 0.45 |
| Interest Coverage | 26.86 |
Financial Efficiency
Return on equity (ROE) is 18.81% and return on invested capital (ROIC) is 12.93%.
| Return on Equity (ROE) | 18.81% |
| Return on Assets (ROA) | 11.89% |
| Return on Capital (ROIC) | 12.93% |
| Revenue Per Employee | $2.36M |
| Profits Per Employee | $951,113 |
| Employee Count | 1,168 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 2.43 |
Taxes
In the past 12 months, UTHR has paid $327.00 million in taxes.
| Income Tax | 327.00M |
| Effective Tax Rate | 22.74% |
Stock Price Statistics
The stock price has increased by +70.29% in the last 52 weeks. The beta is 0.56, so UTHR's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | +70.29% |
| 50-Day Moving Average | 356.37 |
| 200-Day Moving Average | 291.57 |
| Relative Strength Index (RSI) | 68.08 |
| Average Volume (20 Days) | 326,787 |
Short Selling Information
The latest short interest is 2.19 million, so 4.92% of the outstanding shares have been sold short.
| Short Interest | 2.19M |
| Short Previous Month | 2.24M |
| Short % of Shares Out | 4.92% |
| Short % of Float | 5.36% |
| Short Ratio (days to cover) | 6.65 |
Income Statement
In the last 12 months, UTHR had revenue of $2.76 billion and earned $1.11 billion in profits. Earnings per share was $22.72.
| Revenue | 2.76B |
| Gross Profit | 2.45B |
| Operating Income | 1.35B |
| Pretax Income | 1.40B |
| Net Income | 1.11B |
| EBITDA | 1.41B |
| EBIT | 1.35B |
| Earnings Per Share (EPS) | $22.72 |
Balance Sheet
The company has $3.33 billion in cash and $400.00 million in debt, giving a net cash position of $4.21 billion or $94.21 per share.
| Cash & Cash Equivalents | 3.33B |
| Total Debt | 400.00M |
| Net Cash | 4.21B |
| Net Cash Per Share | $94.21 |
| Equity (Book Value) | 6.10B |
| Book Value Per Share | 136.74 |
| Working Capital | 3.13B |
Cash Flow
In the last 12 months, operating cash flow was $1.14 billion and capital expenditures -$238.50 million, giving a free cash flow of $898.10 million.
| Operating Cash Flow | 1.14B |
| Capital Expenditures | -238.50M |
| Free Cash Flow | 898.10M |
| FCF Per Share | $20.12 |
Margins
Gross margin is 88.94%, with operating and profit margins of 48.82% and 40.31%.
| Gross Margin | 88.94% |
| Operating Margin | 48.82% |
| Pretax Margin | 52.17% |
| Profit Margin | 40.31% |
| EBITDA Margin | 51.23% |
| EBIT Margin | 48.82% |
| FCF Margin | 33.55% |
Dividends & Yields
UTHR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.36% |
| Shareholder Yield | 1.36% |
| Earnings Yield | 6.60% |
| FCF Yield | 5.34% |
Analyst Forecast
The average price target for UTHR is $370.86, which is -2.87% lower than the current price. The consensus rating is "Buy".
| Price Target | $370.86 |
| Price Target Difference | -2.87% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 9.13% |
| EPS Growth Forecast (5Y) | 6.87% |
Stock Splits
The last stock split was on September 23, 2009. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 23, 2009 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
UTHR has an Altman Z-Score of 10.01 and a Piotroski F-Score of 6.
| Altman Z-Score | 10.01 |
| Piotroski F-Score | 6 |